Molecular Data Inc. (NASDAQ:MKD) finished Wednesday with an addition of $0.03 to close at $0.40, an upside of 7.41 percent. An average of 12,843,000 shares of common stock have been traded in the last five days. There was a gain of $0.0350 in the past week. The last 20 days have seen an average of 18,910,230 shares traded, while the 50-day average volume stands at 10,034,724.
MKD stock has decreased by -6.98% in the last month. The company shares reached their 1-month lowest point of $0.2714 on 09/27/21. With the stock rallying to its 52-week high on 02/16/21, shares of the company touched a low of $0.27 and a high of $2.23 in 52 weeks. In spite of this, the price is down -82.06% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Molecular Data Inc. (MKD) has a trailing price-to-earnings (P/E) ratio of 17.00 for the broader industry and 13.61 for the sector. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.05.
The quick ratio of Molecular Data Inc. for the recent quarter was 1.00, and the current ratio was 1.00, indicating that the company is able to meet its debt obligations. On the profitability front, the trailing 12-month gross margin is -0.10% against a 5-year average of 0.7%. Molecular Data Inc.’s EBITDA margin is -4.34%, while its operating margin for the same period stands at -4.40%. Its gross profit as reported stood at -$1.56 million compared to revenue of $1.16 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Molecular Data Inc.’s return on assets was -56.10%.
From a technical analysis perspective, let’s take a brief look at Molecular Data Inc. (MKD) price momentum. RSI 9-day as of the close on 13 October was 58.83%, suggesting the stock is Neutral, with historical volatility in this time frame at 122.13%.
As of today, MKD’s price is $0.3773 +9.59% or $0.0350 from its 5-day moving average. MKD is currently trading +16.96% higher than its 20-day SMA and -51.22% lower than its 100-day SMA. However, the stock’s current price level is -32.20% below the SMA50 and -52.95% below the SMA200.
The stochastic %K and %D were 82.31% and 74.00%, respectively, and the average true range (ATR) was 0.0444. With the 14-day stochastic at 87.78% and the average true range at 0.0458, the RSI (14) stands at 53.19%. The stock has reached 0.0233 on the 9-day MACD Oscillator while the 14-day reading was at 0.0415.
The consensus rating for Molecular Data Inc. (MKD) among analysts is -. According to current brokerage recommendations, 0 brokerage firms advise that investors sell MKD, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 0 others rate it as a “buy”.